XML 31 R18.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

ACCRUED EXPENSES | 9 Months Ended
--- | ---
Mar. 31, 2024
ACCRUED EXPENSES |
ACCRUED EXPENSES | (12) ACCRUED EXPENSES Accrued expenses consist of the following:
|  | March 31, |  |  | June 30, |
|  | 2024 |  |  | 2023 |
Clinical / regulatory costs |  | $ | 1,366,822 |  |  | $ | 2,960,126 |
Other research related expenses |  |  | 248,798 |  |  |  | 121,121 |
Professional Services |  |  | 69,840 |  |  |  | 339,258 |
Personnel costs |  |  | - |  |  |  | 1,563,847 |
Selling expenses |  |  | 667,533 |  |  |  | 1,266,653 |
Other |  |  | 11,972 |  |  |  | 260,054 |
|  | $ | 2,364,964 |  |  | $ | 6,511,059 |

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References No definition available. + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration